After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah

After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah

Submitted by admin on October 27, 2024 - 7:48pm
Source: 
Fierce Pharma
News Tags: 
Iterum
antibiotics
UTIs
FDA
Orlynvah
Headline: 
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
snippet: 

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem.

Do Not Allow Advertisers to Use My Personal information